<unk>  is a dopamine and norepinephrine reuptake inhibitor (DNRI) that is FDA approved for the treatment of wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA).   Common adverse reactions include headache, nausea, decreased appetite, insomnia, and anxiety..
Solriamfetol
Lisdexamfetamine
Domiphen
Etilamfetamine
Cabergoline
Dexbrompheniramine
Sertindole
Medifoxamine